MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION: Form 990, tax year 2024
View the entire original 990 at ProPublica ↗
- Organization
- MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION (EIN 31-1611837)
- Tax period
- 2024-07-01 to 2025-06-30
- Filed
- 2026-02-24
- IRS object ID
- 202630559349301013
- Schema version
- 2024v5.5
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2026-02-24T09:34:34-06:00 | ReturnTs |
| Tax Period End | 2025-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 135565207 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | TWO MANHATTAN WEST 375 9TH AVENUE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10001 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2024-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 311611837 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MARC LUSTGARTEN PANCREATIC CANCER | BusinessNameLine1Txt |
| Business Name Line2 | FOUNDATION | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | MARC | BusinessNameControlTxt |
| Phone | 5167371550 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 504 RXR PLAZA | AddressLine1Txt |
| City | UNIONDALE | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 11556 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LINDA TANTAWI | PersonNm |
| Person Title | CEO | PersonTitleTxt |
| Phone | 5167371550 | PhoneNum |
| Signature | 2026-02-23 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | DEVIN L DUNCAN | PreparerPersonNm |
| PTIN | P01249521 | PTIN |
| Phone | 2127589700 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2024 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | LUSTGARTEN FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | LINDA TANTAWI | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 504 RXR PLAZA | AddressLine1Txt |
| City | UNIONDALE | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 11556 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $105,190,515 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.LUSTGARTEN.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1998 | FormationYr |
| Legal Domicile State | NY | LegalDomicileStateCd |
| Activity Or Mission | THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD.THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. THROUGH FY25, THE LUSTGARTEN FOUNDATION HAS INVESTED $301 MILLION IN PANCREATIC CANCER RESEARCH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 16 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 16 | VotingMembersIndependentCnt |
| Total Employee | 26 | TotalEmployeeCnt |
| Total Volunteers | 1059 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $21,134,092 | PYContributionsGrantsAmt |
| CY Contributions Grants | $34,677,585 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,266,888 | PYInvestmentIncomeAmt |
| CY Investment Income | $2,436,168 | CYInvestmentIncomeAmt |
| PY Other Revenue | $348,048 | PYOtherRevenueAmt |
| CY Other Revenue | $76,957 | CYOtherRevenueAmt |
| PY Total Revenue | $22,749,028 | PYTotalRevenueAmt |
| CY Total Revenue | $37,190,710 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $21,875,654 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $18,049,864 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $4,669,479 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $4,909,781 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $53,806 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $25,575 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $3,055,377 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $4,363,615 | PYOtherExpensesAmt |
| CY Other Expenses | $4,194,872 | CYOtherExpensesAmt |
| PY Total Expenses | $30,962,554 | PYTotalExpensesAmt |
| CY Total Expenses | $27,180,092 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$8,213,526 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $10,010,618 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $75,802,153 | TotalAssetsBOYAmt |
| Total Assets EOY | $91,535,774 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $10,919,729 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $12,507,342 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $64,882,424 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $79,028,432 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD. SEE SCHEDULE O.THE LUSTGARTEN FOUNDATION IS BOLDLY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FOCUSES ON TRANSLATING OUR UNDERSTANDING OF THE UNDERLYING BIOLOGY OF PANCREATIC CANCER INTO CLINICAL APPLICATIONS TO CHANGE, EXTEND, AND ULTIMATELY SAVE PATIENTS' LIVES. IN FY25, THE FOUNDATION AWARDED $18 MILLION TO FUEL CUTTING-EDGE PANCREATIC CANCER RESEARCH, INCLUDING 10 NEW GRANTS TO RESEARCHERS AT SEVEN LEADING INSTITUTIONS. RESEARCH EFFORTS ARE CONCENTRATED ON THREE KEY PILLARS: EARLY DETECTION AND INTERCEPTION, DRUG DEVELOPMENT, AND PERSONALIZED MEDICINE. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $19,810,727 | ExpenseAmt |
| Grant | $18,049,864 | GrantAmt |
| Desc | RESEARCH PROGRAM: THE LUSTGARTEN FOUNDATION'S MISSION IS TO ADVANCE THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. 2025 MARKED THE FOUNDATION'S 27TH YEAR OF DRIVING PIONEERING PANCREATIC CANCER RESEARCH BREAKTHROUGHS, ACCELERATING PROGRESS FASTER THAN EVER BEFORE AND PROVIDING A MORE HOPEFUL FUTURE FOR ALL PATIENTS. SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,235,976 | ExpenseAmt |
| Desc | PUBLIC EDUCATION AND INFORMATION PROGRAM: THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS, AND TRANSFORMING PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $773,834 | ExpenseAmt |
| Desc | PROFESSIONAL EDUCATION PROGRAM: PROFESSIONAL EDUCATION FOCUSED ON THE FOUNDATION'S SCIENTIFIC LEADERSHIP CONDUCTING HIGH-LEVEL MEETINGS WITH FUNDED SCIENTISTS AND DIRECTORS OF THE LABS PROGRAM SITES AND COLLABORATING ORGANIZATIONS. ADDITIONALLY, THE LUSTGARTEN FOUNDATION PROVIDED SUPPORT FOR THE AACR SPECIAL CONFERENCE IN PANCREAS CANCER RESEARCH, AACR-LUSTGARTEN FOUNDATION-MARK FOUNDATION JOINT WORKSHOP ON SOLVING THE EARLY STAGE DIAGNOSIS FOR RALCITRANT CANCERS, THE GORDON RESEARCH CONFERENCE ON PANCREATIC DISEASES, THE INTERNATIONAL WOMEN'S DAY SYMPOSIUM AT THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE, AND THE FOUNDATION'S SCIENTIFIC ADVISORY BOARD ANNUAL MEETING. SEE SCHEDULE O. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $21,820,537 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (1) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (1) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 38 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 26 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (1) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (1) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 16 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 16 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ID | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TX | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WY | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | FAISAL JAWAID | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 5167371555 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 504 RXR PLAZA | AddressLine1Txt |
| City | UNIONDALE | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 11556 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (24 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| ANDREW LUSTGARTEN | ||||||||
| CHAIRMAN | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| ROBERT F VIZZA | ||||||||
| CHAIRMAN EMERITUS | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| JENNIE FORTUNOFF | ||||||||
| SECRETARY | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| PHILIP D'AMBROSIO | ||||||||
| TREASURER | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| ADAM SILVER | ||||||||
| VICE CHAIRMAN | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| SOMMER BAZURO PHD | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| JOHN H COBB | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| JESSICA LUSTGARTEN COURTEMANCHE | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| MARCIA LUSTGARTEN | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| SHEILA MAHONY | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| CHARLES R SCHUELER | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| WILLA SHALIT | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| SCOTT PENBERTHY | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| SELWYN VICKERS | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| AARON KANTOFF | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| RICHARD R BARAKAT MD MBA | ||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| LINDA TANTAWI | ||||||||
| CEO | 40.00 | 0.00 | Yes (X) | $489,273 | $0 | $39,510 | ||
| KERRI KAPLAN | ||||||||
| PRESIDENT | 40.00 | 0.00 | Yes (X) | $341,967 | $0 | $40,938 | ||
| FAISAL JAWAID | ||||||||
| CFO | 40.00 | 0.00 | Yes (X) | $287,237 | $0 | $41,045 | ||
| ANDREW RAKEMAN | ||||||||
| VP RESEARCH | 40.00 | 0.00 | $272,473 | $0 | $41,720 | Yes (X) | ||
| GLEN PECK | ||||||||
| SVP TECHNOLOGY & BUSINESS INTELLIGENCE | 40.00 | 0.00 | $268,413 | $0 | $39,490 | Yes (X) | ||
| JACLYN P LYMAN | ||||||||
| HEAD CLINICAL RESEARCH & DEVELOPMENT | 40.00 | 0.00 | $258,870 | $0 | $21,280 | Yes (X) | ||
| STEPHANIE DERGARABEDIAN | ||||||||
| NATIONAL DIRECTOR OF DEVELOPMENT | 40.00 | 0.00 | $179,133 | $0 | $35,668 | Yes (X) | ||
| SUSAN M JACOBSON | ||||||||
| DIRECTOR EXTERNAL & COMMUNITY RELATIONS | 40.00 | 0.00 | $166,081 | $0 | $20,129 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,263,447 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $279,780 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 14 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|---|
| FUSE FUNDRAISING GROUP LLC | ||||||||||
| 12355 SUNRISE VALLEY DRIVE SUITE 24 | RESTON | VA | 20191 | DIRECT MAIL | $720,381 | |||||
| EW GROUP LLC | ||||||||||
| 629 FIFTH AVENUE SUITE 300 | PELHAM | NY | 10803 | EVENT SUPPORT | $232,540 | |||||
| JC GEEVER INC | ||||||||||
| 11 RIVERSIDE DRIVE 2EW | NEW YORK | NY | 10023 | DONOR DEVELOPMENT | $195,862 | |||||
| WALKER STEWART MCKEOUGH | ||||||||||
| 240 CENTRAL PARK SOUTH APT 8P | NEW YORK | NY | 10019 | DONOR DEVELOPMENT | $150,333 | |||||
| WSI PAID SEARCH LTD | ||||||||||
| DIGITAL ADVERTISEMENT | $145,750 | 91 SKYWAY AVE SUITE 104 | TORONTO | ONTORIO | CA | M9W 6R5 | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 6 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $5,537,977 | FundraisingAmt |
| All Other Contributions | $29,139,608 | AllOtherContributionsAmt |
| Noncash Contributions | $392,236 | NoncashContributionsAmt |
| Total Contributions | $34,677,585 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,202,888 | TotalRevenueColumnAmt |
| Exclusion | $2,202,888 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $76,957 | TotalRevenueColumnAmt |
| Exclusion | $76,957 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $68,173,634 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $67,940,354 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $233,280 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $233,280 | TotalRevenueColumnAmt |
| Exclusion | $233,280 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $59,451 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $5,537,977 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $59,451 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $37,190,710 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $2,513,125 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,594,187 | TotalAmt |
| Program Services | $17,594,187 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $455,677 | TotalAmt |
| Program Services | $455,677 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,345,414 | TotalAmt |
| Program Services | $458,239 | ProgramServicesAmt |
| Management And General | $707,627 | ManagementAndGeneralAmt |
| Fundraising | $179,548 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,757,864 | TotalAmt |
| Program Services | $1,413,538 | ProgramServicesAmt |
| Management And General | $521,798 | ManagementAndGeneralAmt |
| Fundraising | $822,528 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $110,764 | TotalAmt |
| Program Services | $53,519 | ProgramServicesAmt |
| Management And General | $24,145 | ManagementAndGeneralAmt |
| Fundraising | $33,100 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $421,261 | TotalAmt |
| Program Services | $165,972 | ProgramServicesAmt |
| Management And General | $115,343 | ManagementAndGeneralAmt |
| Fundraising | $139,946 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $274,478 | TotalAmt |
| Program Services | $122,656 | ProgramServicesAmt |
| Management And General | $76,248 | ManagementAndGeneralAmt |
| Fundraising | $75,574 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,102 | TotalAmt |
| Program Services | $3,102 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $25,575 | TotalAmt |
| Fundraising | $25,575 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $248,375 | TotalAmt |
| Management And General | $248,375 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $824,230 | TotalAmt |
| Program Services | $424,903 | ProgramServicesAmt |
| Management And General | $127,238 | ManagementAndGeneralAmt |
| Fundraising | $272,089 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $740,389 | TotalAmt |
| Program Services | $222,117 | ProgramServicesAmt |
| Management And General | $74,039 | ManagementAndGeneralAmt |
| Fundraising | $444,233 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $482,242 | TotalAmt |
| Program Services | $192,896 | ProgramServicesAmt |
| Management And General | $120,561 | ManagementAndGeneralAmt |
| Fundraising | $168,785 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $112,457 | TotalAmt |
| Program Services | $44,984 | ProgramServicesAmt |
| Management And General | $28,115 | ManagementAndGeneralAmt |
| Fundraising | $39,358 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $247,923 | TotalAmt |
| Program Services | $61,980 | ProgramServicesAmt |
| Management And General | $37,189 | ManagementAndGeneralAmt |
| Fundraising | $148,754 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $38,727 | TotalAmt |
| Program Services | $15,490 | ProgramServicesAmt |
| Management And General | $9,683 | ManagementAndGeneralAmt |
| Fundraising | $13,554 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $40,982 | TotalAmt |
| Program Services | $16,392 | ProgramServicesAmt |
| Management And General | $10,246 | ManagementAndGeneralAmt |
| Fundraising | $14,344 | FundraisingAmt |
Other Expenses OtherExpensesGrp (2 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| DIRECT MAIL DESIGN & PR | $1,149,769 | $574,885 | $172,465 | $402,419 |
| BANK & CREDIT CARD FEES | $291,540 | $15,970 | $275,570 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,136 | TotalAmt |
| Management And General | $15,136 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $27,180,092 | TotalAmt |
| Program Services | $21,820,537 | ProgramServicesAmt |
| Management And General | $2,304,178 | ManagementAndGeneralAmt |
| Fundraising | $3,055,377 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,900,693 | BOYAmt |
| EOY | $2,507,400 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,663,022 | BOYAmt |
| EOY | $11,366,565 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $237,956 | BOYAmt |
| EOY | $337,425 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $343,474 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $178,425 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $34,912 | BOYAmt |
| EOY | $165,049 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $68,965,570 | BOYAmt |
| EOY | $71,046,044 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $5,000,000 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $1,113,291 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $75,802,153 | BOYAmt |
| EOY | $91,535,774 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $917,651 | BOYAmt |
| EOY | $1,042,406 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,002,078 | BOYAmt |
| EOY | $10,332,743 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $17,650 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $1,114,543 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,919,729 | BOYAmt |
| EOY | $12,507,342 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $62,508,499 | BOYAmt |
| EOY | $66,740,484 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,373,925 | BOYAmt |
| EOY | $12,287,948 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $64,882,424 | BOYAmt |
| EOY | $79,028,432 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $75,802,153 | BOYAmt |
| EOY | $91,535,774 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $10,010,618 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $4,135,390 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $15,661,608 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $20,139,699 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $19,131,206 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $21,134,092 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $34,677,585 | CurrentTaxYearAmt |
| Total | $110,744,190 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $15,661,608 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $20,139,699 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $19,131,206 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $21,134,092 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $34,677,585 | CurrentTaxYearAmt |
| Total | $110,744,190 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $8,812,541 | SubstantialContributorsTotAmt |
| Public Support Total170 | $101,931,649 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,252,026 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,704,321 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,599,807 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,265,272 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,279,845 | CurrentTaxYearAmt |
| Total | $11,101,271 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $8,150 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus2 Years | $160,156 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $47,396 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $59,451 | CurrentTaxYearAmt |
| Total | $275,153 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $122,120,614 | TotalSupportAmt |
| Public Support CY170 | 0.83470 | PublicSupportCY170Pct |
| Public Support PY170 | 0.87950 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $43,242 | OtherCostOrOtherBasisAmt |
| Depreciation | $491 | DepreciationAmt |
| Book Value | $42,751 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $9,100 | OtherCostOrOtherBasisAmt |
| Depreciation | $9,100 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $291,132 | OtherCostOrOtherBasisAmt |
| Depreciation | $168,834 | DepreciationAmt |
| Book Value | $122,298 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $165,049 | TotalBookValueLandBuildingsAmt |
Other Securities OtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | PRIVATE CREDIT FUND | Desc |
| Book Value | $5,000,000 | BookValueAmt |
| Method Valuation | F | MethodValuationCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $5,000,000 | TotalBookValueSecuritiesAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | OPERATING LEASE LIABILITY | Desc |
| Amt | $1,114,543 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $1,114,543 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $41,425,607 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $4,135,390 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $347,882 | DonatedServicesAndUseFcltsAmt |
| Revenue Not Reported | $4,483,272 | RevenueNotReportedAmt |
| Revenue Subtotal | $36,942,335 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $248,375 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $248,375 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $37,190,710 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $27,279,599 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $347,882 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $347,882 | ExpensesNotReportedAmt |
| Expenses Subtotal | $26,931,717 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $248,375 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $248,375 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $27,180,092 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE FOUNDATION HAS RECEIVED A FINAL DETERMINATION LETTER FROM THE INTERNAL REVENUE SERVICE STATING THAT THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3). THE FOUNDATION IS TREATED AS A PUBLIC CHARITY AS DEFINED IN SECTIONS 509(A)(1) AND 170(B)(1)(A)(VI). THE FOUNDATION FOLLOWS THE PROVISIONS OF ACCOUNTING STANDARDS CODIFICATION (ASC) SUBTOPIC 740-10, INCOME TAXES OVERALL (ASC 740-10), RELATING TO UNCERTAINTY IN INCOME TAXES. FOR THE FOUNDATION, ASC 740-10 IS PRIMARILY APPLICABLE TO THE INCURRENCE OF UNRELATED BUSINESS INCOME TAX ATTRIBUTABLE TO CERTAIN OF ITS INVESTMENTS. ASC 740-10 ESTABLISHES A MINIMUM THRESHOLD FOR FINANCIAL STATEMENT RECOGNITION OF THE BENEFITS OF POSITIONS TAKEN, OR EXPECTED TO BE TAKEN, IN FILING TAX RETURNS. IT REQUIRES THE EVALUATION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN, IN THE COURSE OF PREPARING THE FOUNDATION'S INCOME TAX RETURNS TO DETERMINE WHETHER THE TAX POSITIONS ARE "MORE LIKELY THAN NOT" OF BEING SUSTAINED BY THE APPLICABLE TAX AUTHORITY. TAX POSITIONS NOT DEEMED TO MEET THE MORE-LIKELY THAN-NOT THRESHOLD ARE RECORDED AS TAX EXPENSE. FOR THE YEARS ENDED JUNE 30, 2025 AND 2024, THE FOUNDATION HAS NOT IDENTIFIED OR PROVIDED FOR ANY SUCH POSITIONS. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| NORTH AMERICA | 0 | 0 | GRANTMAKING | PANCREATIC CANCER RESEARCH | $60,000 |
| EUROPE | 0 | 0 | GRANTMAKING | PANCREATIC CANCER RESEARCH | $395,677 |
| NORTH AMERICA | 0 | 1 | PROGRAM SERVICE | PANCREATIC CANCER RESEARCH | $145,200 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 1 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 1 | TotalEmployeeCnt |
| Subtotal Spent | $600,877 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $600,877 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (3 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt |
|---|---|---|---|---|
| NORTH AMERICA | PANCREATIC CANCER RESEARCH | $60,000 | WIRE/EFT | $0 |
| EUROPE | PANCREATIC CANCER RESEARCH | $340,677 | WIRE/EFT | $0 |
| EUROPE | PANCREATIC CANCER RESEARCH | $55,000 | WIRE/EFT | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 3 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | GRANT MONITORING PROCESS THE ORGANIZATION REQUIRES ALL GRANTEES TO PROVIDE DETAILED REPORTING ON THEIR RESEARCH. REPORTING INCLUDES ACCOUNTING FOR ALL FUNDS AND SHALL BE ACCOMPANIED BY ELECTRONIC COPIES OF ALL ARTICLES, IRRESPECTIVE OF WHETHER THEY WERE PUBLISHED, RESENTED OR OTHERWISE DISCLOSED, CONCERNING GRANT RESEARCH WRITTEN BY THE PRINCIPAL INVESTIGATOR. FINAL GRANT ACCOUNTING IS DUE FROM THE SPONSORING INSTITUTION AND THE INSTITUTIONS AGREE TO REFUND ANY PORTION OF THE GRANT FUNDS TO THE FOUNDATION THAT WAS NOT USED FOR THE SPECIFIED PURPOSES DESCRIBED HEREIN AND RETURN TO THE FOUNDATION ANY UNEXPENDED FUNDS WITHIN THIRTY (30) DAYS AFTER THE EXPIRATION OR TERMINATION OF THE GRANT TERM, OR AT THE FOUNDATION'S OPTION, THE FOUNDATION MAY, BY WRITTEN NOTICE, ALLOW THE SPONSORING INSTITUTION TO USE ANY REMAINING GRANT FUNDS IN FURTHERANCE OF GRANT RESEARCH IN PROGRESS AT THE TIME OF SUCH EXPIRATION. THE FOUNDATION SHALL HAVE THE RIGHT TO AUDIT THE USE OF GRANT FUNDS. PART I, LINE E, COLUMN (F): METHOD OF ACCOUNTING EXPENSES ARE REPORTED USING THE ACCRUAL METHOD OF ACCOUNTING, CONSISTENT WITH THE AUDITED FINANCIAL STATEMENTS. | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| In Person Solicitations | Yes (X) | InPersonSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (1) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Gross ReceiptsGrossReceiptsAmt | Retained By ContractorRetainedByContractorAmt | Net To OrganizationNetToOrganizationAmt |
|---|---|---|---|---|---|---|---|---|
| FUSE FUNDRAISING GROUP LLC | ||||||||
| 12355 SUNRISE VALLEY DRIVE SUITE 2 | RESTON | VA | 20191 | MAIL SOLICITATION | 0 | $3,253,410 | $750,580 | $2,502,830 |
| MM EVENT GROUP LLC | ||||||||
| 110 WEST 40TH STREET SUITE 1403 | NEW YORK | NY | 10018 | EVENT CONSULTING | 0 | $455,174 | $25,575 | $429,599 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $3,708,584 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $776,155 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $2,932,429 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AZ | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DE | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | ID | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | IN | LicensedStatesCd |
| Licensed States | IA | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | MT | LicensedStatesCd |
| Licensed States | NE | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | SD | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | TX | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | VT | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
| Licensed States | WY | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | ROMBO GOLF EVT | Event1Nm |
| Gross Receipts Event1 | $898,264 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $898,264 | CharitableContriEvent1Amt |
| Event2 | LI WALK | Event2Nm |
| Gross Receipts Event2 | $878,911 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $878,911 | CharitableContriEvent2Amt |
| Other Events Total | 103 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $3,820,253 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $3,760,802 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $59,451 | GrossRevenueOtherEventsAmt |
| Food And Beverage Other Events | $42,961 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $13,751 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $2,739 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $5,597,428 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $5,537,977 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $59,451 | GrossRevenueTotalEventsAmt |
| Food And Beverage Total Events | $42,961 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $13,751 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $2,739 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $59,451 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | $0 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (20 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| JOHNS HOPKINS UNIVERSITY | ||||||||
| 1650 ORLEANS STREET | BALTIMORE | MD | 21287 | 520595110 | 501(C)(3) | $6,410,909 | $0 | PANCREATIC CANCER RESEARCH |
| COLD SPRING HARBOR LABORATORY | ||||||||
| ONE BUNGTOWN ROAD | COLD SPRING HARBOR | NY | 11724 | 112013303 | 501(C)(3) | $1,937,943 | $0 | PANCREATIC CANCER RESEARCH |
| AMERICAN ASSOCIATION FOR CANCER RESEARCH | ||||||||
| 615 CHESTNUT STREET- 17TH FLOOR | PHILADELPHIA | PA | 191064404 | 236251648 | 501(C)(3) | $1,593,497 | $0 | PANCREATIC CANCER RESEARCH |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | ||||||||
| 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | 042103594 | 501(C)(3) | $1,000,000 | $0 | PANCREATIC CANCER RESEARCH |
| DANA FARBER CANCER INSTITUTE | ||||||||
| 450 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042263040 | 501(C)(3) | $1,456,615 | $0 | PANCREATIC CANCER RESEARCH |
| THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | ||||||||
| 10010 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 952160097 | 501(C)(3) | $1,000,000 | $0 | PANCREATIC CANCER RESEARCH |
| YALE UNIVERSITY | ||||||||
| PO BOX 1873 | NEW HAVEN | CT | 06508 | 060646973 | 501(C)(3) | $58,049 | $0 | PANCREATIC CANCER RESEARCH |
| MASSACHUSETTES GENERAL HOSPITAL | ||||||||
| 55 FRUIT STREET | BOSTON | MA | 02114 | 042697983 | 501(C)(3) | $175,000 | $0 | PANCREATIC CANCER RESEARCH |
| NYU GROSSMAN SCHOOL OF MEDICINE | ||||||||
| PO BOX 415026 | BOSTON | MA | 02241 | 135562308 | 501(C)(3) | $716,827 | $0 | PANCREATIC CANCER RESEARCH |
| THE TRUSTEE OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||
| 3400 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104 | 231352685 | 501(C)(3) | $500,000 | $0 | PANCREATIC CANCER RESEARCH |
| THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||
| 104 AIRPORT DRIVE | CHAPEL HILL | NC | 27599 | 566001393 | GOV'T | $150,000 | $0 | PANCREATIC CANCER RESEARCH |
| DUKE UNIVERSITY | ||||||||
| PO BOX 104132 | DURHAM | NC | 27708 | 560532129 | 501(C)(3) | $605,443 | $0 | PANCREATIC CANCER RESEARCH |
| MEMORIAL SLOAN KETTERING CANCER CENTER | ||||||||
| 1275 YORK AVENUE | NEW YORK | NY | 10065 | 131924236 | 501(C)(3) | $573,736 | $0 | PANCREATIC CANCER RESEARCH |
| HENRY FORD HEALTH SYSTEM | ||||||||
| 2799 W GRAND BLVD | DETROIT | MI | 48202 | 381357020 | 501(C)(3) | $106,528 | $0 | PANCREATIC CANCER RESEARCH |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| ONE GUSTAVE L LEVY PLACE | NEW YORK | NY | 100296574 | 136171197 | 501(C)(3) | $150,000 | $0 | PANCREATIC CANCER RESEARCH |
| STANFORD UNIVERSITY SCHOOL OF MEDICINE | ||||||||
| 240 PASTEUR DRIVE | PALO ALTO | CA | 94305 | 941156365 | 501(C)(3) | $44,000 | $0 | PANCREATIC CANCER RESEARCH |
| UNIVERSITY OF TEXAS MD ANDERSON CENTER | ||||||||
| 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 746001118 | GOV'T | $369,998 | $0 | PANCREATIC CANCER RESEARCH |
| WEST VIRGINIA UNIVERSITY | ||||||||
| 886 CHESTNUT RIDGE ROAD | MORGANTOWN | WV | 26506 | 556000842 | GOV'T | $330,642 | $0 | PANCREATIC CANCER RESEARCH |
| STAND UP TO CANCER - ENTERTAINMENT INDUSTRY FOUNDATION | ||||||||
| 10880 WILSHIRE BOULEVARD | LOS ANGELES | CA | 90024 | 951644609 | 501(C)(3) | $360,000 | $0 | PANCREATIC CANCER RESEARCH |
| BAYLOR COLLEGE OF MEDICINE | ||||||||
| ONE BAYLOR PLAZA | HOUSTON | TX | 77030 | 741613878 | 501(C)(3) | $55,000 | $0 | PANCREATIC CANCER RESEARCH |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 20 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE FOUNDATION MAKES GRANTS TO 501(C)(3) PUBLIC CHARITIES AND CERTAIN STATE UNIVERSITIES CONDUCTING PANCREATIC CANCER RESEARCH. AS PART OF THE REQUIREMENT FOR RECEIVING SUCH GRANTS, THE FOUNDATION REQUIRES PERIODIC UPDATES AND REPORTING ON SCIENTIFIC PROGRESS AND FINANCIAL EXPENDITURES. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (1) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (8 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LINDA TANTAWI | ||||||||||||||
| CEO | $341,148 | $0 | $143,750 | $0 | $4,375 | $0 | $13,625 | $0 | $25,885 | $0 | $528,783 | $0 | $4,375 | $0 |
| KERRI KAPLAN | ||||||||||||||
| PRESIDENT | $265,969 | $0 | $75,998 | $0 | $0 | $0 | $4,071 | $0 | $36,867 | $0 | $382,905 | $0 | $0 | $0 |
| FAISAL JAWAID | ||||||||||||||
| CFO | $221,087 | $0 | $66,150 | $0 | $0 | $0 | $5,740 | $0 | $35,305 | $0 | $328,282 | $0 | $0 | $0 |
| ANDREW RAKEMAN | ||||||||||||||
| VP RESEARCH | $227,323 | $0 | $45,150 | $0 | $0 | $0 | $7,266 | $0 | $34,454 | $0 | $314,193 | $0 | $0 | $0 |
| GLEN PECK | ||||||||||||||
| SVP TECHNOLOGY & BUSINESS INTELLIGEN | $223,013 | $0 | $45,400 | $0 | $0 | $0 | $6,024 | $0 | $33,466 | $0 | $307,903 | $0 | $0 | $0 |
| JACLYN P LYMAN | ||||||||||||||
| HEAD CLINICAL RESEARCH & DEVELOPMENT | $224,370 | $0 | $34,500 | $0 | $0 | $0 | $5,418 | $0 | $15,862 | $0 | $280,150 | $0 | $0 | $0 |
| STEPHANIE DERGARABEDIAN | ||||||||||||||
| NATIONAL DIRECTOR OF DEVELOPMENT | $155,883 | $0 | $23,250 | $0 | $0 | $0 | $3,958 | $0 | $31,710 | $0 | $214,801 | $0 | $0 | $0 |
| SUSAN M JACOBSON | ||||||||||||||
| DIRECTOR EXTERNAL & COMMUNITY RELATI | $148,441 | $0 | $17,640 | $0 | $0 | $0 | $3,826 | $0 | $16,303 | $0 | $186,210 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 4B: | NONQUALIFIED RETIREMENT PLAN LINDA TANTAWI, CEO, PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN THROUGH 3/31/24. DURING THE 2024 CALENDAR YEAR, $4,375 WAS DISTRIBUTED FROM THE PLAN AND IS INCLUDED IN OTHER REPORTABLE COMPENSATION ON SCHEDULE J, PART II, COLUMN (B)(III). THIS AMOUNT HAD BEEN REPORTED AS DEFERRED COMPENSATION IN PRIOR YEARS AND IS THEREFORE ALSO INCLUDED ON SCHEDULE J, PART II, COLUMN (F). |
| PART I, LINE 7: | NONFIXED PAYMENTS IN 2024, OFFICERS AND EMPLOYEES RECEIVED NONFIXED DISCRETIONARY BONUSES AS REPORTED ON SCHEDULE J, PART II, COLUMN (B)(II). |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 33 | ContributionCnt |
| Noncash Contributions Rpt F990 | $392,236 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | AVG MKT VALUE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (1) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE M, PART I, COLUMN (B) | FormAndLineReferenceDesc |
| Explanation | THE AMOUNT IN COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 4A | RESEARCH PROGRAM $19,810,727 GRANTS $18,049,864 THE LUSTGARTEN FOUNDATION'S MISSION IS TO ADVANCE THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. 2025 MARKED THE FOUNDATION'S 27TH YEAR OF DRIVING PIONEERING PANCREATIC CANCER RESEARCH BREAKTHROUGHS, ACCELERATING PROGRESS FASTER THAN EVER BEFORE AND PROVIDING A MORE HOPEFUL FUTURE FOR ALL PATIENTS. IN 2025, THE FOUNDATION AWARDED 10 NEW GRANTS TOTALING UP TO $13.9 MILLION TO RESEARCHERS AT EIGHT LEADING INSTITUTIONS. OF THE NEW GRANTS AWARDED, 30% SUPPORT DRUG DEVELOPMENT PROJECTS; 14% SUPPORT EARLY DETECTION AND INTERCEPTION EFFORTS; AND 20% SUPPORT PERSONALIZED MEDICINE STUDIES. WITH THE ADDITION OF THESE NEW GRANTS, THE FOUNDATION NOW SUPPORTS 51 ACTIVE GRANTS ACROSS 20 INSTITUTIONS. THE CUMULATIVE TOTAL THE LUSTGARTEN FOUNDATION INVESTED IN RESEARCH THROUGH JUNE 2025 IS $301 MILLION. DURING FY25, MAJOR LUSTGARTEN-FUNDED INITIATIVES INCLUDED: - ADVANCING THE LUSTGARTEN FOUNDATION'S COMMITMENT TO FUNDING EARLY DETECTION PROJECTS, MARCIA CANTO, MD, DIRECTOR OF CLINICAL RESEARCH, DIVISION OF GASTROENTEROLOGY AT JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE WAS AWARDED A GRANT FOR HER STUDY "ARTIFICIAL INTELLIGENCE-AUGMENTED EARLY DETECTION AND PREVENTION OF PANCREATIC CANCER." FUNDING THE DEVELOPMENT AND DELIVERY OF TOOLS TO ENABLE EARLY DIAGNOSIS OF PANCREATIC CANCER, INCLUDING SCREENING IN THE GENERAL POPULATION AND APPROACHES FOR RISK ASSESSMENT, MANAGEMENT, AND INTERCEPTION IN HIGH-RISK GROUPS WILL ULTIMATELY GIVE PATIENTS AND THEIR FAMILIES MORE HELP AND MORE HOPE THAN EVER BEFORE. - LUSTGARTEN FOUNDATION-AACR CAREER DEVELOPMENT AWARDS HONORING RUTH BADER GINSBURG AND JOHN ROBERT LEWIS AWARDED TO ANUPRIYA SINGHAL, MD, PHD, MEMORIAL SLOAN KETTERING CANCER CENTER, FOR HER STUDY "INTERROGATING VULNERABILITIES OF A KRAS INHIBITOR-RESISTANT CELL STATE IN PANCREATIC CANCER, AND VINCENT BERNARD PAGAN, MD, PHD, THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, FOR HIS STUDY "TARGETING ONCOGENIC METABOLIC ADAPTATIONS TO OVERCOME THERAPY RESISTANCE IN PANCREATIC CANCER." THE AWARDS SUPPORT TRAILBLAZING INVESTIGATORS COMMITTED TO INCREASING THE UNDERSTANDING AND TREATMENT OF PANCREATIC CANCER. THESE AWARDS SUPPORT CAREER ADVANCEMENT AND THE DEVELOPMENT OF PROMISING TALENT IN PANCREATIC CANCER RESEARCH, IN HONOR OF THE LIVES AND LEGACIES OF TWO ICONIC AMERICANS LOST TO PANCREATIC CANCER. - LUSTGARTEN EQUITY, ACCESSIBILITY, AND DIVERSITY (LEAD) PROJECT GRANT AWARDED TO NINA STEELE, PHD, UNIVERSITY OF CINCINNATI, AND HOWARD CRAWFORD, PHD, HENRY FORD PANCREATIC CANCER CENTER, FOR THEIR PROJECT "RACIAL DISPARITIES IN PANCREATIC CANCER." THIS PROJECT WILL ENABLE DRS. STEELE AND CRAWFORD TO DEVELOP TOOLS THAT WILL ALLOW RESEARCHERS TO BETTER UNDERSTAND THE COMPLEXITY AND HETEROGENEITY OF PANCREATIC CANCER. - INNOVATION AND COLLABORATION PROGRAM GRANTS AWARDED TO RONALD PARCHEM, PHD, BAYLOR COLLEGE OF MEDICINE FOR HIS STUDY, "MECHANISMS DRIVING TUMOR INNERVATION IN PANCREATIC CANCER, AND MASSIMILIANO MAZZONE, PHD, GROUP LEADER AT THE VIB-KU LEUVEN CENTER FOR CANCER BIOLOGY AND PROFESSOR IN THE DEPARTMENT OF ONCOLOGY AT KU LEUVEN FOR HIS STUDY "UNRAVELING THE ROLE OF P2Y6+ MACROPHAGES IN PDAC LIVER METASTASIS." - DR. ROBERT F. VIZZA LUSTGARTEN CLINICAL ACCELERATOR INITIATIVE (CAI) GRANTS AWARDED TO GREGORY BEATTY, MD, PHD, ASSOCIATE PROFESSOR OF MEDICINE (HEMATOLOGY-ONCOLOGY) AT THE UNIVERSITY OF PENNSYLVANIA PERELMAN SCHOOL OF MEDICINE FOR HIS STUDY "COMBINATORIAL MYELOID ACTIVATION AS IMMUNOTHERAPY FOR METASTATIC PANCREATIC CANCER," DUNG LE, MD, PROFESSOR OF ONCOLOGY AT JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE FOR HER STUDY "NC410 AND FOLFIRINOX IN COMBINATION WITH ANTI-PD-1 WITH AND WITHOUT ANTI-CTLA-4 FOR TREATMENT NAIVE METASTATIC PANCREATIC CANCER," KEVIN C. SOARES, MD, ASSISTANT ATTENDING SURGEON OF HEPATOPANCREATOBILIARY SURGERY AT MEMORIAL SLOAN KETTERING CANCER CENTER (MSK) FOR HIS STUDY "A PILOT STUDY OF NEOADJUVANT MFOLFIRINOX AND ELI-002 7P WITH OR WITHOUT ANTI-PD-1 CHECKPOINT BLOCKADE IN BORDERLINE AND RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA, AND BRIAN BOONE, MD, ASSISTANT PROFESSOR IN THE DEPARTMENT OF SURGICAL ONCOLOGY AND AN ADJUNCT ASSISTANT PROFESSOR IN THE DEPARTMENT OF MICROBIOLOGY, IMMUNOLOGY, AND CELL BIOLOGY AT WEST VIRGINIA UNIVERSITY FOR HIS STUDY "TARGETING MYELOPEROXIDASE TO ENHANCE CHEMOTHERAPY RESPONSE IN PANCREATIC ADENOCARCINOMA." THE CAI REDUCES THE TIME FROM CLINICAL TRIAL CONCEPT TO LAUNCH USING A LUSTGARTEN-DEVELOPED PROCESS BASED ON THE BEST AVAILABLE SCIENCE AND EMPLOYING INNOVATIVE BIOMARKERS. TO MAXIMIZE THE VALUE OF THE CAI STUDIES, THE LUSTGARTEN FOUNDATION CONTINUED TO DEVELOP THE LUSTGARTEN UNITED CLINICAL INFORMATION DATABASE (LUCID) TO HOUSE THE CHARACTERISTICS OF PATIENTS ACROSS STUDIES AND LINK THEM TO PATIENT OUTCOMES. BY PROVIDING A CENTRALIZED PLATFORM FOR DATA SHARING AND ANALYSIS, LUCID PROMOTES COLLABORATION BETWEEN RESEARCHERS, LEADING TO FASTER RESEARCH ADVANCEMENTS. ADDITIONALLY, LUCID WILL HELP RESEARCHERS IDENTIFY NEW TREATMENT APPROACHES AND BIOMARKERS AND UNDERSTAND DISEASE HETEROGENEITY AND PATIENT SUBGROUPS, DETERMINING WAYS TO MATCH THE RIGHT PATIENTS TO THE RIGHT TREATMENTS AND IMPROVE OUTCOMES. - THE LUSTGARTEN ADVANCING BREAKTHROUGH SCIENCE (LABS) PROGRAM, A HALLMARK OF THE FOUNDATION'S UNIQUE RESEARCH STRATEGY, HAD AN INCREDIBLY SUCCESSFUL YEAR ADVANCING RESEARCH AT ITS SIX DEDICATED LABORATORIES. OF NOTE: FROM THE LABS SITES AT DANA-FARBER CANCER INSTITUTE, LED BY BRIAN WOLPIN, MD, MPH, AND MIT, LED BY TYLER JACKS, PHD, FINDINGS PUBLISHED IN SCIENCE IDENTIFIED A PREVIOUSLY UNRECOGNIZED CLASS OF PANCREATIC CANCER RESTRICTED "CRYPTIC" ANTIGENSTARGETS DERIVED FROM NONCODING REGIONS OF THE GENOME THAT CAN BE RECOGNIZED BY T CELLS. THE STUDY SHOWED THAT MANY OF THESE ANTIGENS ARE SHARED ACROSS PATIENTS, ABSENT FROM HEALTHY TISSUE, AND CAPABLE OF DRIVING POTENT IMMUNE RESPONSES IN PRECLINICAL MODELS. BY REVEALING NEW, BROADLY APPLICABLE IMMUNE TARGETS, THIS WORK OPENS PROMISING PATHWAYS FOR DEVELOPING NEXT-GENERATION THERAPIES FOR A DISEASE THAT HAS LONG RESISTED IMMUNOTHERAPY. FROM THE LABS SITE AT COLD SPRING HARBOR LABORATORY, LED BY DAVID TUVESON, MD, PHD, LUSTGARTEN'S CHIEF SCIENTIST, FINDINGS PUBLISHED IN CANCER RESEARCH SHOWED THAT INHIBITING THE FGFR2 PROTEIN ALONE AND IN COMBINATION WITH EGFRCAN SIGNIFICANTLY DELAY OR PREVENT TUMOR FORMATION IN PRECLINICAL MODELS. BY TARGETING THE MOLECULAR SIGNALS THAT DRIVE EARLY DISEASE PROGRESSION, THIS WORK ESTABLISHES A FOUNDATION FOR INTERVENING BEFORE PANCREATIC CANCER BECOMES CLINICALLY AGGRESSIVE, OPENING THE DOOR TO PREVENTION STRATEGIES FOR HIGH-RISK INDIVIDUALS. FROM THE LABS SITE AT THE SALK INSTITUTE, LED BY REUBEN SHAW, PHD, FINDINGS PUBLISHED IN THE JOURNAL OF CLINICAL INVESTIGATION REVEALED THAT A SPECIFIC CELL-SURFACE SUGAR, HSAT, PLAYS A PROTECTIVE ROLE IN PANCREATIC CANCER-SUPPRESSING INFLAMMATION, LIMITING TUMOR SPREAD, AND CORRELATING WITH IMPROVED SURVIVAL. THE STUDY ALSO DEMONSTRATED THAT HSAT IS DETECTABLE IN PATIENT BLOOD SAMPLES, POSITIONING IT AS BOTH A PROMISING THERAPEUTIC TARGET AND A POTENTIAL BIOMARKER. BY UNCOVERING A NEW LINK BETWEEN TUMOR BIOLOGY, INFLAMMATION, AND DISEASE PROGRESSION, THIS WORK OPENS NEW AVENUES FOR EARLIER INTERVENTION AND MORE EFFECTIVE TREATMENT STRATEGIES. THE LABS PROGRAM PROVIDES LONG-TERM FUNDING TO PROMOTE THE DEVELOPMENT OF INNOVATIVE IDEAS AND SPEED THE PACE OF DISCOVERY BY INCENTIVIZING INTERDISCIPLINARY TEAM SCIENCE, INCLUDING GROUPS WITH COMPLEMENTARY EXPERTISE ACROSS THE PIPELINE FROM TARGET DISCOVERY AND VALIDATION TO PRECLINICAL DEVELOPMENT AND CLINICAL TESTING. - IN 2025, LUSTGARTEN CONTINUED OUR COLLABORATIONS WITH ORGANIZATIONS INCLUDING THE PANCREATIC CANCER COLLECTIVE, AMERICAN ASSOCIATION FOR CANCER RESEARCH, SWIM ACROSS AMERICA, BREAK THROUGH CANCER, AS WELL AS ESTABLISHED A NEW RELATIONSHIP WITH THE MARK FOUNDATION FOR CANCER RESEARCH. THROUGH THESE PARTNERSHIPS, LUSTGARTEN BRINGS FOCUS AND STRATEGY TO PANCREATIC CANCER RESEARCH AND MAXIMIZES OUR COLLECTIVE FINANCIAL INVESTMENT SO WE CAN FUND THE MOST HIGH-RISK, HIGH-REWARD SCIENCE. THIS COLLABORATIVE APPROACH YIELDED SIGNIFICANT PROGRESS THIS YEAR. LANDMARK RESULTS FROM THE PANCREATIC ADENOCARCINOMA SIGNATURE STRATIFICATION FOR TREATMENT (PASS-01) TRIAL, SUPPORTED BY THE LUSTGARTEN FOUNDATION AND STAND UP TO CANCER THROUGH THE PANCREATIC CANCER COLLECTIVE, WERE PUBLISHED IN THE JOURNAL OF CLINICAL ONCOLOGY. PASS-01, THE FIRST RANDOMIZED, HEAD-TO-HEAD COMPARISON OF THE TWO CURRENT STANDARD-OF-CARE REGIMENS FOR METASTATIC PANCREATIC CANCER, SET A NEW BAR FOR WHAT CLINICAL TRIALS CAN ACHIEVE BY PAIRING THERAPY RESPONSE DATA WITH UNPRECEDENTED MOLECULAR AND GENOMIC PROFILING OF EACH PATIENT'S TUMOR AND ESTABLISHED A SHARED, MULTI-INSTITUTIONAL FRAMEWORK FOR UNDERSTANDING PANCREATIC CANCER BIOLOGY. |
| FORM 990, PART III, LINE 4B | PUBLIC EDUCATION AND INFORMATION PROGRAM $1,235,976 THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS, AND TRANSFORMING PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. THE LUSTGARTEN FOUNDATION CREATED, PRINTED AND DISTRIBUTED MATERIALS TO UPDATE PATIENTS, CAREGIVERS, SURVIVORS, DONORS, VOLUNTEERS, WALK AND EVENT LEADERS AND CORPORATE SPONSORS ON RESEARCH DEVELOPMENTS, FOUNDATION MILESTONES, AND WALKS/EVENTS. MATERIALS INCLUDED: - LUSTGARTENLIVE! SERIES OF RESEARCH-FOCUSED, INTERACTIVE WEBINARS - PROGRESS & PROMISE NEWSLETTER - ANNUAL REPORT - IMPACT REPORT - RESEARCH MILESTONES UPDATE - MONTHLY E-NEWSLETTER WITH VIDEO INTRODUCTION - DIRECT MAIL AND ACQUISITION MAIL PIECES - MONTHLY PANCCHATS ON TWITTER, BRINGING EXPERTS AND PATIENTS TOGETHER TO DISCUSS TOPICS PERTINENT TO THE PANCREATIC CANCER COMMUNITY - INCREASED FOCUS ON VIDEO WE ALSO CONTINUED DISTRIBUTING OUR NAVIGATING PANCREATIC CANCER: A GUIDE FOR PATIENTS & CAREGIVERS HANDBOOK, CONTAINING INFORMATION ON MANAGING A PANCREATIC CANCER DIAGNOSIS AND TREATING THE DISEASE. THE BOOK AND MANY OF THE MATERIALS NOTED ABOVE ARE ACCESSIBLE AT WWW.LUSTGARTEN.ORG. |
| FORM 990, PART III, LINE 4C | PROFESSIONAL EDUCATION PROGRAM $773,834 PROFESSIONAL EDUCATION FOCUSED ON THE FOUNDATION'S SENIOR LEADERSHIP CONDUCTING HIGH-LEVEL MEETINGS WITH FUNDED SCIENTISTS AND DIRECTORS OF THE LABS PROGRAM SITES AND COLLABORATING ORGANIZATIONS, AS WELL AS ATTENDING/PRESENTING AT SCIENTIFIC MEETINGS FOR ORGANIZATIONS INCLUDING THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) AND STAND UP TO CANCER (SU2C). ADDITIONALLY, THE LUSTGARTEN FOUNDATION PROVIDED SUPPORT FOR THE AACR SPECIAL CONFERENCE IN PANCREAS CANCER RESEARCH, AACR-LUSTGARTEN FOUNDATION-MARK FOUNDATION JOINT WORKSHOP ON SOLVING THE EARLY STAGE DIAGNOSIS FOR RECALCITRANT CANCERS, THE GORDON RESEARCH CONFERENCE ON PANCREATIC DISEASES. THE INTERNATIONAL WOMEN'S DAY SYMPOSIUM AT THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE, AND THE PANCREAS COURSE AT COLD SPRING HARBOR LABORATORY. |
| FORM 990, PART VI, SECTION A, LINE 2 | MARCIA LUSTGARTEN, ANDREW LUSTGARTEN AND JESSICA LUSTGARTEN COURTEMANCHE - FAMILY RELATIONSHIP. |
| FORM 990, PART VI, SECTION B, LINE 11B | FORM 990 IS REVIEWED BY THE CHIEF FINANCE OFFICER FOR ACCURACY AND REASONABLENESS PRIOR TO SUBMISSION TO THE IRS. ADDITIONALLY, A COMPLETE COPY OF THE FINAL RETURN IS PROVIDED TO ALL VOTING BOARD MEMBERS PRIOR TO FILING WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE ORGANIZATION HAS A WRITTEN CONFLICT OF INTEREST POLICY. THE WRITTEN POLICY REQUIRES ANNUAL DISCLOSURES BY ALL MEMBERS OF THE BOARD OF DIRECTORS, OFFICERS, AND KEY PERSONS OF ANY INTEREST THAT COULD GIVE RISE TO CONFLICT. THE ORGANIZATION REGULARLY AND CONSISTENTLY MONITORS AND ENFORCES THE COMPLIANCE OF THE CONFLICT OF INTEREST POLICY. IN THE INSTANCE WHERE A DIRECTOR HAS A CONFLICT, THEY ARE ASKED BY THE BOARD CHAIR TO RECUSE THEMSELVES FROM DELIBERATIONS, DECISIONS AND THE VOTE. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER IS REVIEWED AND APPROVED ANNUALLY (MOST RECENTLY ON JUNE 2, 2025) BY THE FINANCE COMMITTEE OF THE BOARD. TO SUPPORT THIS PROCESS, THE COMMITTEE UTILIZES A COMPENSATION SURVEY PROVIDED BY AN INDEPENDENT HUMAN RESOURCES CONSULTANT. |
| FORM 990, PART VI, SECTION C, LINE 19 | AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE ON THE ORGANIZATION'S WEBSITE. IN ADDITION, GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. |